JP5681199B2 - フッ化第一スズとクエン酸亜鉛および低レベルの水を含む歯磨き剤 - Google Patents
フッ化第一スズとクエン酸亜鉛および低レベルの水を含む歯磨き剤 Download PDFInfo
- Publication number
- JP5681199B2 JP5681199B2 JP2012536771A JP2012536771A JP5681199B2 JP 5681199 B2 JP5681199 B2 JP 5681199B2 JP 2012536771 A JP2012536771 A JP 2012536771A JP 2012536771 A JP2012536771 A JP 2012536771A JP 5681199 B2 JP5681199 B2 JP 5681199B2
- Authority
- JP
- Japan
- Prior art keywords
- composition
- stannous
- ions
- polyphosphate
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000551 dentifrice Substances 0.000 title claims description 100
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims description 34
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 title claims description 17
- 229960002799 stannous fluoride Drugs 0.000 title claims description 17
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 title description 9
- 239000011746 zinc citrate Substances 0.000 title description 9
- 235000006076 zinc citrate Nutrition 0.000 title description 9
- 229940068475 zinc citrate Drugs 0.000 title description 9
- 239000000203 mixture Substances 0.000 claims description 292
- 229920000388 Polyphosphate Polymers 0.000 claims description 62
- 239000001205 polyphosphate Substances 0.000 claims description 62
- 235000011176 polyphosphates Nutrition 0.000 claims description 62
- -1 fluoride ions Chemical class 0.000 claims description 48
- 150000002500 ions Chemical class 0.000 claims description 37
- 239000002562 thickening agent Substances 0.000 claims description 25
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 21
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 claims description 19
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 claims description 18
- 235000019832 sodium triphosphate Nutrition 0.000 claims description 18
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 17
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 17
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 17
- 229910052783 alkali metal Inorganic materials 0.000 claims description 15
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 claims description 13
- 235000019818 tetrasodium diphosphate Nutrition 0.000 claims description 13
- 239000007853 buffer solution Substances 0.000 claims description 10
- 235000011180 diphosphates Nutrition 0.000 claims description 8
- 239000001509 sodium citrate Substances 0.000 claims description 7
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 claims description 5
- 125000004437 phosphorous atom Chemical group 0.000 claims description 5
- IUTCEZPPWBHGIX-UHFFFAOYSA-N tin(2+) Chemical compound [Sn+2] IUTCEZPPWBHGIX-UHFFFAOYSA-N 0.000 claims description 3
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 claims description 3
- 229940038773 trisodium citrate Drugs 0.000 claims description 3
- UNXRWKVEANCORM-UHFFFAOYSA-I triphosphate(5-) Chemical compound [O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O UNXRWKVEANCORM-UHFFFAOYSA-I 0.000 claims description 2
- 229940091249 fluoride supplement Drugs 0.000 description 30
- 238000009472 formulation Methods 0.000 description 30
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 25
- 239000004480 active ingredient Substances 0.000 description 22
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 21
- 150000003839 salts Chemical class 0.000 description 21
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 18
- 239000003795 chemical substances by application Substances 0.000 description 16
- 229910021645 metal ion Inorganic materials 0.000 description 15
- 239000000080 wetting agent Substances 0.000 description 14
- 239000000606 toothpaste Substances 0.000 description 13
- 238000000034 method Methods 0.000 description 12
- 239000000377 silicon dioxide Substances 0.000 description 12
- 239000003981 vehicle Substances 0.000 description 12
- 239000003082 abrasive agent Substances 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- 229940034610 toothpaste Drugs 0.000 description 11
- 239000004599 antimicrobial Substances 0.000 description 10
- 239000002585 base Substances 0.000 description 10
- 235000011187 glycerol Nutrition 0.000 description 10
- 150000002978 peroxides Chemical class 0.000 description 10
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 9
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 8
- 230000008901 benefit Effects 0.000 description 8
- 239000003086 colorant Substances 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 229920000642 polymer Polymers 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 239000000230 xanthan gum Substances 0.000 description 8
- 229920001285 xanthan gum Polymers 0.000 description 8
- 235000010493 xanthan gum Nutrition 0.000 description 8
- 229940082509 xanthan gum Drugs 0.000 description 8
- 239000011230 binding agent Substances 0.000 description 7
- 230000001680 brushing effect Effects 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 7
- 210000000214 mouth Anatomy 0.000 description 7
- 230000008719 thickening Effects 0.000 description 7
- 229960003500 triclosan Drugs 0.000 description 7
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 6
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 6
- 239000003945 anionic surfactant Substances 0.000 description 6
- 230000002272 anti-calculus Effects 0.000 description 6
- 125000004432 carbon atom Chemical group C* 0.000 description 6
- 235000010418 carrageenan Nutrition 0.000 description 6
- 229920001525 carrageenan Polymers 0.000 description 6
- 150000004676 glycans Chemical class 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 229920001282 polysaccharide Polymers 0.000 description 6
- 239000005017 polysaccharide Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000004094 surface-active agent Substances 0.000 description 6
- 229910052725 zinc Inorganic materials 0.000 description 6
- 239000011701 zinc Substances 0.000 description 6
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 5
- 125000000217 alkyl group Chemical group 0.000 description 5
- 239000002280 amphoteric surfactant Substances 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 239000008365 aqueous carrier Substances 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 239000006172 buffering agent Substances 0.000 description 5
- 239000000679 carrageenan Substances 0.000 description 5
- 229940113118 carrageenan Drugs 0.000 description 5
- 235000013355 food flavoring agent Nutrition 0.000 description 5
- 229920001983 poloxamer Polymers 0.000 description 5
- 229920001223 polyethylene glycol Polymers 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 4
- 229910019142 PO4 Inorganic materials 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 239000012062 aqueous buffer Substances 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- VVYPIVJZLVJPGU-UHFFFAOYSA-L copper;2-aminoacetate Chemical compound [Cu+2].NCC([O-])=O.NCC([O-])=O VVYPIVJZLVJPGU-UHFFFAOYSA-L 0.000 description 4
- 239000004205 dimethyl polysiloxane Substances 0.000 description 4
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 4
- 235000021317 phosphate Nutrition 0.000 description 4
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 4
- 150000008442 polyphenolic compounds Chemical class 0.000 description 4
- 235000013824 polyphenols Nutrition 0.000 description 4
- 229940048084 pyrophosphate Drugs 0.000 description 4
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 4
- 239000011775 sodium fluoride Substances 0.000 description 4
- 235000013024 sodium fluoride Nutrition 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000004408 titanium dioxide Substances 0.000 description 4
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- 229940090898 Desensitizer Drugs 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 229920000161 Locust bean gum Polymers 0.000 description 3
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 3
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 125000001931 aliphatic group Chemical group 0.000 description 3
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 235000010980 cellulose Nutrition 0.000 description 3
- 239000013522 chelant Substances 0.000 description 3
- 239000007979 citrate buffer Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 230000003628 erosive effect Effects 0.000 description 3
- 235000003599 food sweetener Nutrition 0.000 description 3
- 230000036571 hydration Effects 0.000 description 3
- 238000006703 hydration reaction Methods 0.000 description 3
- 235000010420 locust bean gum Nutrition 0.000 description 3
- 239000000711 locust bean gum Substances 0.000 description 3
- 239000002736 nonionic surfactant Substances 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 239000006072 paste Substances 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 125000001453 quaternary ammonium group Chemical group 0.000 description 3
- 210000003296 saliva Anatomy 0.000 description 3
- 239000002002 slurry Substances 0.000 description 3
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 239000003765 sweetening agent Substances 0.000 description 3
- 150000003606 tin compounds Chemical class 0.000 description 3
- 239000011576 zinc lactate Substances 0.000 description 3
- 235000000193 zinc lactate Nutrition 0.000 description 3
- 229940050168 zinc lactate Drugs 0.000 description 3
- TXUICONDJPYNPY-UHFFFAOYSA-N (1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) heptanoate Chemical compound C1CC2CC(=O)C=C(C)C2(C)C2C1C1CCC(OC(=O)CCCCCC)C1(C)CC2 TXUICONDJPYNPY-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- 241001474374 Blennius Species 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 239000004343 Calcium peroxide Substances 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- VUNOFAIHSALQQH-UHFFFAOYSA-N Ethyl menthane carboxamide Chemical compound CCNC(=O)C1CC(C)CCC1C(C)C VUNOFAIHSALQQH-UHFFFAOYSA-N 0.000 description 2
- 229920002148 Gellan gum Polymers 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- 235000006679 Mentha X verticillata Nutrition 0.000 description 2
- 235000002899 Mentha suaveolens Nutrition 0.000 description 2
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 229920003072 Plasdone™ povidone Polymers 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 2
- ZNOZWUKQPJXOIG-XSBHQQIPSA-L [(2r,3s,4r,5r,6s)-6-[[(1r,3s,4r,5r,8s)-3,4-dihydroxy-2,6-dioxabicyclo[3.2.1]octan-8-yl]oxy]-4-[[(1r,3r,4r,5r,8s)-8-[(2s,3r,4r,5r,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-sulfonatooxyoxan-2-yl]oxy-4-hydroxy-2,6-dioxabicyclo[3.2.1]octan-3-yl]oxy]-5-hydroxy-2-( Chemical compound O[C@@H]1[C@@H](O)[C@@H](OS([O-])(=O)=O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H]2OC[C@H]1O[C@H](O[C@H]1[C@H]([C@@H](CO)O[C@@H](O[C@@H]3[C@@H]4OC[C@H]3O[C@H](O)[C@@H]4O)[C@@H]1O)OS([O-])(=O)=O)[C@@H]2O ZNOZWUKQPJXOIG-XSBHQQIPSA-L 0.000 description 2
- 239000000908 ammonium hydroxide Substances 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 230000033558 biomineral tissue development Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 235000001465 calcium Nutrition 0.000 description 2
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 2
- LHJQIRIGXXHNLA-UHFFFAOYSA-N calcium peroxide Chemical compound [Ca+2].[O-][O-] LHJQIRIGXXHNLA-UHFFFAOYSA-N 0.000 description 2
- 235000019402 calcium peroxide Nutrition 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 239000002826 coolant Substances 0.000 description 2
- 238000005115 demineralization Methods 0.000 description 2
- 230000002328 demineralizing effect Effects 0.000 description 2
- 208000002925 dental caries Diseases 0.000 description 2
- 210000004268 dentin Anatomy 0.000 description 2
- 229940008099 dimethicone Drugs 0.000 description 2
- CBOQJANXLMLOSS-UHFFFAOYSA-N ethyl vanillin Chemical group CCOC1=CC(C=O)=CC=C1O CBOQJANXLMLOSS-UHFFFAOYSA-N 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000010492 gellan gum Nutrition 0.000 description 2
- 239000000216 gellan gum Substances 0.000 description 2
- 208000007565 gingivitis Diseases 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229940074371 monofluorophosphate Drugs 0.000 description 2
- 229920001992 poloxamer 407 Polymers 0.000 description 2
- 229940044476 poloxamer 407 Drugs 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 235000011118 potassium hydroxide Nutrition 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 229940071207 sesquicarbonate Drugs 0.000 description 2
- 229910002028 silica xerogel Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000011121 sodium hydroxide Nutrition 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 239000001119 stannous chloride Substances 0.000 description 2
- 235000011150 stannous chloride Nutrition 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- FWPIDFUJEMBDLS-UHFFFAOYSA-L tin(II) chloride dihydrate Chemical compound O.O.Cl[Sn]Cl FWPIDFUJEMBDLS-UHFFFAOYSA-L 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical group [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- 239000009637 wintergreen oil Substances 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- 150000003751 zinc Chemical class 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- BHHYHSUAOQUXJK-UHFFFAOYSA-L zinc fluoride Chemical compound F[Zn]F BHHYHSUAOQUXJK-UHFFFAOYSA-L 0.000 description 2
- 239000011670 zinc gluconate Substances 0.000 description 2
- 235000011478 zinc gluconate Nutrition 0.000 description 2
- 229960000306 zinc gluconate Drugs 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- VRGNUPCISFMPEM-ZVGUSBNCSA-L zinc;(2r,3r)-2,3-dihydroxybutanedioate Chemical compound [Zn+2].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O VRGNUPCISFMPEM-ZVGUSBNCSA-L 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- YXTDAZMTQFUZHK-ZVGUSBNCSA-L (2r,3r)-2,3-dihydroxybutanedioate;tin(2+) Chemical compound [Sn+2].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O YXTDAZMTQFUZHK-ZVGUSBNCSA-L 0.000 description 1
- IKWIHXXSGVHFEZ-UHFFFAOYSA-N (4-tert-butyl-2-methylphenyl) acetate Chemical compound CC(=O)OC1=CC=C(C(C)(C)C)C=C1C IKWIHXXSGVHFEZ-UHFFFAOYSA-N 0.000 description 1
- DTOUUUZOYKYHEP-UHFFFAOYSA-N 1,3-bis(2-ethylhexyl)-5-methyl-1,3-diazinan-5-amine Chemical compound CCCCC(CC)CN1CN(CC(CC)CCCC)CC(C)(N)C1 DTOUUUZOYKYHEP-UHFFFAOYSA-N 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- JCPGMXJLFWGRMZ-UHFFFAOYSA-N 1-(2-hydroxyphenyl)-3-phenylpropan-1-one Chemical compound OC1=CC=CC=C1C(=O)CCC1=CC=CC=C1 JCPGMXJLFWGRMZ-UHFFFAOYSA-N 0.000 description 1
- RMSOEGBYNWXXBG-UHFFFAOYSA-N 1-chloronaphthalen-2-ol Chemical compound C1=CC=CC2=C(Cl)C(O)=CC=C21 RMSOEGBYNWXXBG-UHFFFAOYSA-N 0.000 description 1
- YFVBASFBIJFBAI-UHFFFAOYSA-M 1-tetradecylpyridin-1-ium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCC[N+]1=CC=CC=C1 YFVBASFBIJFBAI-UHFFFAOYSA-M 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- CLWNPUARORRDFD-UHFFFAOYSA-N 2-hydroxybutanedioic acid;zinc Chemical compound [Zn].OC(=O)C(O)CC(O)=O CLWNPUARORRDFD-UHFFFAOYSA-N 0.000 description 1
- RSEBUVRVKCANEP-UHFFFAOYSA-N 2-pyrroline Chemical compound C1CC=CN1 RSEBUVRVKCANEP-UHFFFAOYSA-N 0.000 description 1
- ANAAMBRRWOGKGU-UHFFFAOYSA-M 4-ethyl-1-tetradecylpyridin-1-ium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCC[N+]1=CC=C(CC)C=C1 ANAAMBRRWOGKGU-UHFFFAOYSA-M 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-M Aminoacetate Chemical compound NCC([O-])=O DHMQDGOQFOQNFH-UHFFFAOYSA-M 0.000 description 1
- 239000004875 Anti-Odour Agent Substances 0.000 description 1
- 241000205585 Aquilegia canadensis Species 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 239000004604 Blowing Agent Substances 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 241000099774 Cuscuta salina Species 0.000 description 1
- UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- 229930182827 D-tryptophan Natural products 0.000 description 1
- QIVBCDIJIAJPQS-SECBINFHSA-N D-tryptophane Chemical compound C1=CC=C2C(C[C@@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-SECBINFHSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 208000006558 Dental Calculus Diseases 0.000 description 1
- 108010001682 Dextranase Proteins 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- QSJXEFYPDANLFS-UHFFFAOYSA-N Diacetyl Chemical group CC(=O)C(C)=O QSJXEFYPDANLFS-UHFFFAOYSA-N 0.000 description 1
- OJIYIVCMRYCWSE-UHFFFAOYSA-M Domiphen bromide Chemical compound [Br-].CCCCCCCCCCCC[N+](C)(C)CCOC1=CC=CC=C1 OJIYIVCMRYCWSE-UHFFFAOYSA-M 0.000 description 1
- 229920005682 EO-PO block copolymer Polymers 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 1
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- QWZLBLDNRUUYQI-UHFFFAOYSA-M Methylbenzethonium chloride Chemical compound [Cl-].CC1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 QWZLBLDNRUUYQI-UHFFFAOYSA-M 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical class OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 229920000805 Polyaspartic acid Polymers 0.000 description 1
- 108010020346 Polyglutamic Acid Proteins 0.000 description 1
- 229920002690 Polyoxyl 40 HydrogenatedCastorOil Polymers 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 241000790234 Sphingomonas elodea Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- FMRLDPWIRHBCCC-UHFFFAOYSA-L Zinc carbonate Chemical compound [Zn+2].[O-]C([O-])=O FMRLDPWIRHBCCC-UHFFFAOYSA-L 0.000 description 1
- YDHWWBZFRZWVHO-UHFFFAOYSA-H [oxido-[oxido(phosphonatooxy)phosphoryl]oxyphosphoryl] phosphate Chemical compound [O-]P([O-])(=O)OP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O YDHWWBZFRZWVHO-UHFFFAOYSA-H 0.000 description 1
- YGCFIWIQZPHFLU-UHFFFAOYSA-N acesulfame Chemical compound CC1=CC(=O)NS(=O)(=O)O1 YGCFIWIQZPHFLU-UHFFFAOYSA-N 0.000 description 1
- 229960005164 acesulfame Drugs 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical class Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 1
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 1
- 125000004103 aminoalkyl group Chemical group 0.000 description 1
- DVARTQFDIMZBAA-UHFFFAOYSA-O ammonium nitrate Chemical class [NH4+].[O-][N+]([O-])=O DVARTQFDIMZBAA-UHFFFAOYSA-O 0.000 description 1
- VBIXEXWLHSRNKB-UHFFFAOYSA-N ammonium oxalate Chemical compound [NH4+].[NH4+].[O-]C(=O)C([O-])=O VBIXEXWLHSRNKB-UHFFFAOYSA-N 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- ZRALSGWEFCBTJO-UHFFFAOYSA-N anhydrous guanidine Natural products NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 1
- 229920006318 anionic polymer Polymers 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000003373 anti-fouling effect Effects 0.000 description 1
- 230000003610 anti-gingivitis Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000002882 anti-plaque Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical class C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 229940043256 calcium pyrophosphate Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 150000005323 carbonate salts Chemical class 0.000 description 1
- 150000003857 carboxamides Chemical class 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 229940001468 citrate Drugs 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 1
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 239000003975 dentin desensitizing agent Substances 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- PNOXNTGLSKTMQO-UHFFFAOYSA-L diacetyloxytin Chemical compound CC(=O)O[Sn]OC(C)=O PNOXNTGLSKTMQO-UHFFFAOYSA-L 0.000 description 1
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 1
- RBLGLDWTCZMLRW-UHFFFAOYSA-K dicalcium;phosphate;dihydrate Chemical compound O.O.[Ca+2].[Ca+2].[O-]P([O-])([O-])=O RBLGLDWTCZMLRW-UHFFFAOYSA-K 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- PXLWOFBAEVGBOA-UHFFFAOYSA-N dihydrochalcone Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=CC(C(=O)CC(O)C=2C=CC(O)=CC=2)=C1O PXLWOFBAEVGBOA-UHFFFAOYSA-N 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 229920005645 diorganopolysiloxane polymer Polymers 0.000 description 1
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical class C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 1
- XJWSAJYUBXQQDR-UHFFFAOYSA-M dodecyltrimethylammonium bromide Chemical compound [Br-].CCCCCCCCCCCC[N+](C)(C)C XJWSAJYUBXQQDR-UHFFFAOYSA-M 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229940073505 ethyl vanillin Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 150000004673 fluoride salts Chemical class 0.000 description 1
- OMRRUNXAWXNVFW-UHFFFAOYSA-N fluoridochlorine Chemical compound ClF OMRRUNXAWXNVFW-UHFFFAOYSA-N 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 229960002737 fructose Drugs 0.000 description 1
- UPBDXRPQPOWRKR-UHFFFAOYSA-N furan-2,5-dione;methoxyethene Chemical compound COC=C.O=C1OC(=O)C=C1 UPBDXRPQPOWRKR-UHFFFAOYSA-N 0.000 description 1
- 229940083124 ganglion-blocking antiadrenergic secondary and tertiary amines Drugs 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 150000002357 guanidines Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229960001375 lactose Drugs 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229960002160 maltose Drugs 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 125000005341 metaphosphate group Chemical group 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N methyl acetate Chemical compound COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- 229960002285 methylbenzethonium chloride Drugs 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 150000003867 organic ammonium compounds Chemical class 0.000 description 1
- MPQXHAGKBWFSNV-UHFFFAOYSA-N oxidophosphanium Chemical group [PH3]=O MPQXHAGKBWFSNV-UHFFFAOYSA-N 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- 239000010663 parsley oil Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- SATCULPHIDQDRE-UHFFFAOYSA-N piperonal Chemical compound O=CC1=CC=C2OCOC2=C1 SATCULPHIDQDRE-UHFFFAOYSA-N 0.000 description 1
- 230000007406 plaque accumulation Effects 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229960000502 poloxamer Drugs 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 108010064470 polyaspartate Proteins 0.000 description 1
- 229920002643 polyglutamic acid Polymers 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 229940045916 polymetaphosphate Drugs 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- ZVJHJDDKYZXRJI-UHFFFAOYSA-N pyrroline Natural products C1CC=NC1 ZVJHJDDKYZXRJI-UHFFFAOYSA-N 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 239000001296 salvia officinalis l. Substances 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical class C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 229960001462 sodium cyclamate Drugs 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- 229940045885 sodium lauroyl sarcosinate Drugs 0.000 description 1
- 229940075560 sodium lauryl sulfoacetate Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 229940045919 sodium polymetaphosphate Drugs 0.000 description 1
- 235000019830 sodium polyphosphate Nutrition 0.000 description 1
- 229940048086 sodium pyrophosphate Drugs 0.000 description 1
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007962 solid dispersion Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 229940007163 stannous tartrate Drugs 0.000 description 1
- SFVFIFLLYFPGHH-UHFFFAOYSA-M stearalkonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 SFVFIFLLYFPGHH-UHFFFAOYSA-M 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 230000019635 sulfation Effects 0.000 description 1
- 238000005670 sulfation reaction Methods 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- VVGOCOMZRGWHPI-UHFFFAOYSA-N trans-hept-4-enal Natural products CCC=CCCC=O VVGOCOMZRGWHPI-UHFFFAOYSA-N 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 229910000406 trisodium phosphate Inorganic materials 0.000 description 1
- 235000019801 trisodium phosphate Nutrition 0.000 description 1
- VSJRDSLPNMGNFG-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate;trihydrate Chemical compound O.O.O.[Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O VSJRDSLPNMGNFG-UHFFFAOYSA-H 0.000 description 1
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 description 1
- 239000011667 zinc carbonate Substances 0.000 description 1
- 235000004416 zinc carbonate Nutrition 0.000 description 1
- 229910000010 zinc carbonate Inorganic materials 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- 229960001939 zinc chloride Drugs 0.000 description 1
- 229940085658 zinc citrate trihydrate Drugs 0.000 description 1
- 150000003752 zinc compounds Chemical class 0.000 description 1
- 229960001296 zinc oxide Drugs 0.000 description 1
- LRXTYHSAJDENHV-UHFFFAOYSA-H zinc phosphate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O LRXTYHSAJDENHV-UHFFFAOYSA-H 0.000 description 1
- 229910000165 zinc phosphate Inorganic materials 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/24—Phosphorous; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/30—Characterized by the absence of a particular group of ingredients
- A61K2800/31—Anhydrous
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Emergency Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Cosmetics (AREA)
Description
[0044]本態様はポリリン酸塩の供給源を含んでいてもよい。ポリリン酸塩は、歯石の形成を抑制するのを促進することで知られている。しかし、約4よりも大きい平均の鎖の長さを有するポリリン酸塩は、口腔組成物のpHを変化させることに加えて、周囲温度において口腔組成物中のイオン性フッ化物と反応して、モノフルオロリン酸塩イオンを生成することも知られている。この反応は、口腔組成物の効能、および組成物が口腔の表面に安定したイオン性フッ化物とポリリン酸塩を供給する能力をそこなうかもしれない。また、安定したポリリン酸塩を供給するためには、口腔組成物の総含水量とpHを、ポリリン酸塩の加水分解が低減するように制御するべきである、ということも知られている。
[0047]本組成物を調製する際に、1種以上の水性担体を組成物に添加するのが望ましい。そのような物質は当分野で周知であり、調製される組成物のために望ましい物理的性質や審美的性質に基づいて当業者によって容易に選択される。典型的には、水性担体は、歯磨き剤組成物の重量に基づいて、約40%〜約99%の割合で含まれ、好ましくは約70%〜約98%、そしてより好ましくは約90%〜約95%の割合で含まれる。
[0048]商業的に適切な口腔組成物の調製において用いられる水は、イオン含有量が低く、そして有機不純物を含んでいないことが好ましい。この歯磨き剤組成物において、水は一般的に、組成物の重量に基づいて約10%未満、好ましくは約0%〜約6%の割合で含まれるだろう。ポリリン酸塩およびフッ化物や第一スズのような有効成分は、この組成物においてそのような低レベルの水には溶解しない。しかし、これらの成分は、この組成物において他の低極性溶媒には溶解して、非イオン分子構造を形成するだろう。いずれの場合にも、それらの有効成分は、貯蔵されている間、組成物中で安定した状態を維持する。フッ化物イオンと第一スズイオンは、もし存在する場合、ブラシで歯磨きを行う際に唾液および/または水と接触するときに、それらの塩の形態または非イオン溶液の形態から放出されるだろう。従って、例えば二つに仕切られた包装を使用することによって、組成物のイオン性有効成分を含有する部分から組成物のポリリン酸塩を含有する部分を物理的に分離する必要はない。さらに、本組成物においては様々な供給源からのフッ化物イオンを有効に用いることができて、米国特許6190644号の「ポリリン酸塩とモノフルオロリン酸ナトリウムを含有する歯磨き剤組成物」に先行して記載されている組成物中のポリリン酸塩と最も適合するフッ化物イオンの供給源としてモノフルオロリン酸ナトリウムを優先して使用するようなことはない。
結合剤系
[0050]本発明の歯磨き剤組成物は好ましくは、架橋ポリビニルピロリドンをガムと組み合わせて含む結合剤系を有している。結合剤系はさらに、多糖類、カルボマー(carbomers)、ポロキサマー、改質セルロース、およびこれらの混合物、および少なくとも1種の湿潤剤からなる群から選択される少なくとも1種の追加の増粘剤を含んでいてもよい。増粘剤は、組成物の重量に基づいて、約0.05%〜約3%の割合で含まれ、そして好ましくは約0.1%〜1.5%の割合で含まれる。これらの結合剤系は、低水分組成物に望ましい粘ちゅう度(コンシステンシー)とゲル化を与える。水に望ましい流動性を与えるゲル化物質と湿潤剤は、それらのゲル化結合特性を活性化するための水が存在しないときは、一般に不十分な流動性を与える、ということがこれまで知られていた。このことは、グリセリン湿潤剤については特に当てはまると考えられる。この結合剤系は、追加の無機増粘剤をさらに含んでいてもよい。
[0051]ここで用いるのに適した、ガムを含めた多糖類としては、カラギーナン、ゲランガム、ローカストビーンガム、キサンタンガム、およびこれらの混合物がある。カラギーナンは海藻由来の多糖類であり、練り歯磨きにおける結合剤または増粘剤として用いられることが知られている(例えば、米国特許6187293号(B1)および米国特許6162418号を参照されたい)。海藻の種類および/または硫酸化の程度と位置によって区別することのできる幾つかのタイプのカラギーナンが存在する。本発明において用いるのに適したものは、カッパカラギーナン、改質カッパカラギーナン、イオタカラギーナン、改質イオタカラギーナン、およびこれらの混合物である。ここで用いるのに適したカラギーナンとしては、FMC Companyから「Viscarin」という一連の名称で市販されているものがあり、それにはViscarin TP 329、Viscarin TP 388、およびViscarin TP 389がある(これらには限定されない)。
[0056]低水分の基剤においては、ヒドロキシエチルセルロースのような改質セルロースも良好な増粘剤である。本組成物においては水分のレベルが限定されているので、グリセリン、プロピレングリコールおよびPEGのような他の低極性溶媒中でのこの増粘剤の溶解性と水和性を増大させるために、疎水性の鎖(C12−C20)を有する改質ヒドロキシエチルセルロースが好ましい。
[0057]湿潤剤は、練り歯磨き組成物が空気に触れたときに硬化することから守るのに役立ち、また特定の湿潤剤は、練り歯磨き組成物に望ましい甘味を与えることもできる。本発明において用いるのに適した湿潤剤としては、グリセリン、ソルビトール、ポリエチレングリコール、プロピレングリコール、キシリトール、およびその他の食用に適する多価アルコールがある。好ましいのは、グリセリン、ポリエチレングリコール、ポリプロピレングリコール、およびこれらの混合物であり、特にこれらの混合物が好ましい。湿潤剤は一般に、組成物の重量に基づいて、約0.1%〜70%の割合で含まれ、好ましくは約1%〜約60%、そしてより好ましくは約15%〜55%の割合で含まれる。
[0059]結合剤系はさらに、コロイドマグネシウムアルミニウムシリケートまたは微細シリカのような追加の無機増粘剤を含んでいてもよく、それによって口当たり(texture)がさらに改善される。追加の無機増粘剤は、もし存在する場合、歯磨き剤組成物の重量に基づいて、約0.1%〜約15%の量、より好ましくは約0.1%〜約5%の量で用いることができる。
[0060]本発明の歯磨き剤組成物は好ましくは、フッ化物イオンの供給源、第一スズイオンの供給源、亜鉛イオンの供給源、およびこれらの混合物からなる群から選択される有効な量のイオン性有効成分を含む。
[0061]ここでのフッ化物イオンの供給源は、遊離したフッ化物イオンを与えることのできる可溶性フッ化物の供給源である。可溶性のフッ化物イオンの供給源としては、フッ化ナトリウム、フッ化第一スズ、フッ化インジウム、フッ化亜鉛、およびモノフルオロリン酸ナトリウムがある。フッ化ナトリウムとフッ化第一スズは、好ましい可溶性のフッ化物イオンの供給源である。米国特許2946725号(Norris他、1960年7月26日発行)および米国特許3678154号(Widder他、1972年7月18日発行)は、そのようなフッ化物イオンの供給源やその他のものを開示している。
[0064]本発明は、第一スズイオン、亜鉛イオン、またはこれらの混合物を与える金属イオンの供給源を含んでいてもよい。金属イオンの供給源は、第一スズまたは亜鉛のイオンと無機または有機対イオンとの、可溶性の化合物またはわずかに可溶性の化合物とすることができる。例としては、フルオリド(フッ化物)、クロリド(塩化物)、クロロフルオリド、アセテート、ヘキサフルオロジルコネート、スルフェート、タルトレート、グルコネート、シトレート、マレート、グリシネート、ピロホスフェート、メタホスフェート、オキサレート、ホスフェート、カーボネートの塩、および第一スズおよび亜鉛の酸化物がある。
[0070]ここで記述される組成物は、先に説明した予備混合物において用いられる第一スズイオンのためのキレート化緩衝剤の他にも緩衝剤を含んでいてもよい。ここで用いられる緩衝剤とは、組成物のpHを約pH3.0〜約pH10の範囲に調整するために用いることのできる薬剤を指す。第一スズを含む歯磨き剤の相は、典型的には約3.0〜約5.5、好ましくは約3.25〜約5、そしてより好ましくは約3.4〜約4.5のスラリーのpHを有するだろう。ポリリン酸塩を含む歯磨き剤の相は、典型的には約4.0〜約10、好ましくは約4.5〜約8、そしてより好ましくは約5.0〜約7.0のスラリーのpHを有するだろう。第一スズとポリリン酸塩の両者を単一相に含む歯磨き剤は、典型的には約4〜約7、好ましくは約4.5〜約6、そしてより好ましくは約5〜約5.5のpHを有するだろう。
[0072]ここで記述される組成物は、抗歯石剤として、歯石の形成に関係するリン酸カルシウム鉱物質の沈積を低減させるのに有効なものとして知られるポリリン酸塩物質を用いてもよい。そのような薬剤としては、ピロリン酸塩およびトリポリリン酸塩がある。この組成物においては、合成アニオンポリマー(これには、ポリアクリル酸エステル、および例えば米国特許4627977号(Gaffar他)に記載されている無水マレイン酸またはマレイン酸とメチルビニルエーテルとのコポリマー(例えばGANTREZ(登録商標))、さらには例えば、ポリアミノプロパンスルホン酸(AMPS)がある)、クエン酸亜鉛三水和物、ジホスホネート(例えばEHDP、AHP)、ポリペプチド(例えばポリアスパラギン酸およびポリグルタミン酸)、およびこれらの混合物を用いてもよい。
[0073]この練り歯磨き組成物には研磨物質も含まれていてもよい。本発明の組成物において用いるために考えられる研磨物質は、歯の象牙質を過度にすり減らすことのない任意の物質とすることができる。典型的な研磨物質としては、ゲルおよび沈殿物を含めたシリカ、アルミナ、オルトリン酸塩を含めたリン酸塩、ポリメタリン酸塩、およびピロリン酸塩、およびこれらの混合物がある。具体的な例としては、オルトリン酸二カルシウム二水和物、ピロリン酸カルシウム、リン酸三カルシウム、ポリメタリン酸カルシウム、不溶性ポリメタリン酸ナトリウム、水和アルミナ、ベータピロリン酸カルシウム、炭酸カルシウム、および尿素とホルムアルデヒドの粒状縮合物のような樹脂研磨物質、および米国特許3070510号(Cooley他、1962年12月25日発行)に開示されているようなその他のものがある。研磨剤の混合物を用いてもよい。歯磨き剤組成物または特定の相が約4以上の平均の鎖の長さを有するポリリン酸塩を含む場合は、カルシウムを含有する研磨剤およびアルミナは好ましい研磨剤ではない。最も好ましい研磨剤はシリカである。
[0075]本発明は、組成物中に過酸化物の供給源を含んでいてもよい。過酸化物の供給源は、過酸化水素、過酸化カルシウム、過酸化尿素、およびこれらの混合物からなる群から選択される。好ましい過酸化物の供給源は過酸化カルシウムである。過酸化物の供給源は過酸化物の原料以外の成分を含んでいてもよいが、過酸化物の原料の量は以下の量で示される。本組成物は過酸化物の供給源を、歯磨き剤組成物の重量に基づいて、約0.01%〜約10%、好ましくは約0.1%〜約5%、より好ましくは約0.2%〜約3%、そして最も好ましくは約0.3%〜約0.8%含んでいてもよい。
[0076]本組成物はアルカリ金属の重炭酸塩も含んでいてもよい。アルカリ金属の重炭酸塩は水に可溶性であり、安定でない限りは、水性系の中で二酸化炭素を放出する傾向がある。重炭酸ナトリウム(重曹としても知られる)は好ましいアルカリ金属重炭酸塩である。アルカリ金属の重炭酸塩は緩衝剤としても機能する。本組成物はアルカリ金属の重炭酸塩を、歯磨き剤組成物の重量に基づいて、約0.5%〜約50%、好ましくは約0.5%〜約30%、より好ましくは約2%〜約20%、そして最も好ましくは約5%〜約18%含んでいてもよい。
[0077]本組成物は界面活性剤も含んでいてもよく、これは一般に発泡剤とも呼ばれる。適当な界面活性剤は、適度に安定であって広いpH範囲にわたって泡立つものである。界面活性剤は、陰イオン性のもの、非イオン性のもの、両性のもの、双性イオン性のもの、陽イオン性のもの、またはこれらの混合物であってよい。ここで有用な陰イオン界面活性剤としては、アルキル基に8〜20個の炭素原子を有する硫酸アルキルの水溶性の塩(例えばアルキル硫酸ナトリウム)、および8〜20個の炭素原子を有する脂肪酸のスルホン化モノグリセリドの水溶性の塩がある。ラウリル硫酸ナトリウムおよびココナツモノグリセリドスルホン酸ナトリウムは、このタイプの陰イオン界面活性剤の例である。その他の適当な陰イオン界面活性剤は、サルコシン酸塩(例えばラウロイルサルコシン酸ナトリウム)、タウリン酸塩、ラウリルスルホ酢酸ナトリウム、ラウロイルイセチオン酸ナトリウム、ラウレスカルボン酸ナトリウム、およびドデシルベンゼンスルホン酸ナトリウムである。陰イオン界面活性剤の混合物も用いることができる。多くの適当な陰イオン界面活性剤が、米国特許3959458号(Agricola他、1976年5月25日発行)によって開示されている。
[0090]本態様を実施するにあたって、使用者は、例えば白化、息の新鮮化、虫歯の予防、痛みの緩和、歯茎の健康、歯石の制御、浸食の制御などの所望の効果を得るために、人間または動物の歯の表面の所望の領域にこの歯磨き剤組成物を適用するだけでよい。歯の表面の浸食を制御するための歯磨き剤の使用あるいは脱ミネラル化(鉱物質除去)を防止するための歯磨き剤の使用は公知であり、例えば米国特許6685920号に記載されていて、その開示の全体がここに参考文献として取り込まれる。歯磨き剤組成物が歯に適用されるときに最良の利益が達成されると考えられるが、この組成物は、歯肉の組織または粘膜の組織のような、他の口腔表面に適用されてもよい。歯磨き剤組成物は直接か間接的かのいずれかで歯および/または口腔の表面に接触してもよいが、しかし歯磨き剤組成物は直接に適用されるのが好ましい。歯磨き剤組成物はいかなる手段で適用されてもよいが、しかしブラシを用いるか、あるいは歯磨き剤のスラリーを用いてすすぐことによって適用するのが好ましい。
[0093]表1に示される配合を有する歯磨き剤組成物が調製された。
[0096]配合Aと配合Cに従う歯磨き剤組成物は、第一スズ塩の安定性を判定するために促進老化の調査に供された。歯磨き剤組成物は4週間にわたって105°Fの温度に供された。可溶性のスズ(これは利用できる第一スズイオンを表す)の初期の量と最終の量が、試験の始めと終わりにおいて測定された。結果を表2に示す。
実施例3
[00100]上述した老化の調査によって、配合Aと配合Cの組成物における他の有効成分の安定性も調査された。その結果を表3に示す。
[00102]第一スズ塩と亜鉛の塩を含む配合物の抗細菌性の効能を測定するために、配合Cの組成物が、模造の口腔における生体外での抗細菌性試験に供された。この配合物の抗細菌性の効能は、抗細菌性成分として0.3%のトリクロサンを含む市販用の歯磨き剤と同等であった。
[00103]配合Bの配合物は、架橋ポリビニルピロリドンとガム(特にキサンタンガム)の混合物を含んでいた。より詳細には、この組成物は1重量%のポリプラスドン(Polyplasdone)XL−10と0.25重量%のキサンタンガムを含んでいた。
Claims (10)
- 架橋ポリビニルピロリドンとガムの組み合わせの増粘剤を含む、経口許容性のあるビヒクル、
フッ化物イオンの供給源、
第一スズイオンの供給源、
亜鉛イオンの供給源、
3個以下のリンの原子を有する無機ポリリン酸塩からなる群から選択される少なくとも1種のポリリン酸塩、および
クエン酸とクエン酸三ナトリウムの混合物を含む緩衝剤系
を単一相に含む歯磨き剤組成物であって、
ここでこの歯磨き剤組成物は、組成物の重量に基づいて10%未満の総含水量を有する、前記歯磨き剤組成物。 - 少なくとも1種のポリリン酸塩は、ピロリン酸塩のアルカリ金属塩、トリポリリン酸塩のアルカリ金属塩、およびこれらの混合物からなる群から選択される、請求項1に記載の組成物。
- 少なくとも1種のポリリン酸塩は、ピロリン酸四ナトリウム、トリポリリン酸ナトリウム、およびこれらの混合物からなる群から選択される、請求項2に記載の組成物。
- 少なくとも1種のポリリン酸塩は、ピロリン酸四ナトリウムとトリポリリン酸ナトリウムとの混合物を含む、請求項3に記載の組成物。
- ピロリン酸四ナトリウムとトリポリリン酸ナトリウムとの混合物は、ピロリン酸四ナトリウムとトリポリリン酸ナトリウムとをおよそ2:3の重量比で含む、請求項4に記載の組成物。
- 少なくとも1種のポリリン酸塩は、組成物の1〜10重量%の割合で含まれる、請求項1に記載の組成物。
- 少なくとも1種のポリリン酸塩は、組成物の3〜7重量%の割合で含まれる、請求項6に記載の組成物。
- フッ化物イオンの供給源と第一スズイオンの供給源はフッ化第一スズを含む、請求項1に記載の組成物。
- 緩衝剤系は組成物の0.1〜10重量%の割合で含まれる、請求項1に記載の組成物。
- 緩衝剤系は、第一スズイオンの供給源の(重量基準での)量よりも多い量(重量基準での量)で存在する、請求項1に記載の組成物。
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2009/062452 WO2011053291A1 (en) | 2009-10-29 | 2009-10-29 | Dentifrice comprising stannous fluoride plus zinc citrate and low levels of water |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2013509404A JP2013509404A (ja) | 2013-03-14 |
JP5681199B2 true JP5681199B2 (ja) | 2015-03-04 |
Family
ID=42333470
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012536771A Expired - Fee Related JP5681199B2 (ja) | 2009-10-29 | 2009-10-29 | フッ化第一スズとクエン酸亜鉛および低レベルの水を含む歯磨き剤 |
Country Status (15)
Country | Link |
---|---|
US (5) | US9968803B2 (ja) |
EP (1) | EP2493445B1 (ja) |
JP (1) | JP5681199B2 (ja) |
CN (1) | CN102596154B (ja) |
AR (1) | AR078814A1 (ja) |
AU (1) | AU2009354789B2 (ja) |
BR (1) | BR112012009305B8 (ja) |
CA (1) | CA2775444C (ja) |
IN (1) | IN2012DN02657A (ja) |
MX (1) | MX347064B (ja) |
MY (1) | MY159488A (ja) |
RU (1) | RU2523900C2 (ja) |
TW (1) | TWI440473B (ja) |
WO (1) | WO2011053291A1 (ja) |
ZA (1) | ZA201202766B (ja) |
Families Citing this family (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5681199B2 (ja) | 2009-10-29 | 2015-03-04 | コルゲート・パーモリブ・カンパニーColgate−Palmolive Company | フッ化第一スズとクエン酸亜鉛および低レベルの水を含む歯磨き剤 |
CN103260705A (zh) * | 2010-01-29 | 2013-08-21 | 高露洁-棕榄公司 | 用于敏感釉质护理的口腔护理产品 |
EP2713990B1 (en) * | 2011-06-02 | 2018-03-21 | Colgate-Palmolive Company | Low water metal ion dentifrice |
US9877929B2 (en) | 2011-10-13 | 2018-01-30 | Premier Dental Products Company | Topical vitamin D and ubiquinol oral supplement compositions |
US10123953B2 (en) * | 2012-06-21 | 2018-11-13 | The Procter & Gamble Company | Reduction of tooth staining derived from cationic antimicrobials |
US9724542B2 (en) | 2012-10-12 | 2017-08-08 | Premier Dental Products Company | Remineralizing and desensitizing compositions, treatments and methods of manufacture |
US9877930B2 (en) | 2012-10-12 | 2018-01-30 | Premier Dental Products Company | Topical ubiquinol oral supplement compositions with amorphous calcium phosphate |
MX353216B (es) | 2012-12-19 | 2018-01-08 | Colgate Palmolive Co | Productos antitranspirantes con proteinas y sales antitranspirantes. |
CA2892182C (en) | 2012-12-19 | 2020-09-15 | Colgate-Palmolive Company | Zinc-lysine complex |
MX352556B (es) | 2012-12-19 | 2017-11-29 | Colgate Palmolive Co | Productos para el cuidado oral que comprenden óxido de zinc y trimetilglicina. |
US10188112B2 (en) | 2012-12-19 | 2019-01-29 | Colgate-Palmolive Company | Personal cleansing compositions containing zinc amino acid/trimethylglycine halide |
US9675823B2 (en) | 2012-12-19 | 2017-06-13 | Colgate-Palmolive Company | Two component compositions containing zinc amino acid halide complexes and cysteine |
CN104853721B (zh) | 2012-12-19 | 2017-10-27 | 高露洁-棕榄公司 | 锌精氨酸/赖氨酸卤化物 |
US9498421B2 (en) | 2012-12-19 | 2016-11-22 | Colgate-Palmolive Company | Two component compositions containing tetrabasic zinc-amino acid halide complexes and cysteine |
US9504858B2 (en) | 2012-12-19 | 2016-11-29 | Colgate-Palmolive Company | Zinc amino acid halide complex with cysteine |
US9750670B2 (en) | 2012-12-19 | 2017-09-05 | Colgate-Palmolive Company | Zinc amino acid complex with cysteine |
US9925130B2 (en) | 2012-12-19 | 2018-03-27 | Colgate-Palmolive Company | Composition with zinc amino acid/trimethylglycine halide precursors |
BR112015014444B1 (pt) | 2012-12-19 | 2019-10-01 | Colgate-Palmolive Company | Uso de um complexo de halogeneto de zinco aminoácido, composição que compreende um complexo de halogeneto de zinco aminoácido e método de limpeza de um dente |
BR112015014900B1 (pt) | 2012-12-19 | 2019-05-14 | Colgate-Palmolive Company | Dentifrício compreendendo um complexo haleto de aminoácidozinco e uso de uma fonte de íon de zinco junto com um aminoácido |
EP2934443B1 (en) | 2012-12-19 | 2017-09-06 | Colgate-Palmolive Company | Oral care compositions comprising zinc amino acid halides |
RU2634269C2 (ru) | 2012-12-19 | 2017-10-24 | Колгейт-Палмолив Компани | Продукты для ухода за полостью рта, содержащие четырехосновный хлорид цинка и триметилглицин |
BR112015014899B1 (pt) | 2012-12-19 | 2019-05-14 | Colgate-Palmolive Company | Colutório compreendendo complexo halogeneto de zinco aminoácido e seus usos |
CA2892421C (en) | 2012-12-19 | 2019-10-01 | Colgate-Palmolive Company | Oral care products comprising a tetrabasic zinc - amino acid - halide complex |
US9499772B2 (en) * | 2013-03-13 | 2016-11-22 | Battelle Energy Alliance, Llc | Methods of decontaminating surfaces and related compositions |
WO2015022141A1 (en) * | 2013-08-16 | 2015-02-19 | Unilever N.V. | Oral care composition |
AU2013399515B2 (en) * | 2013-09-02 | 2017-08-10 | Block Drug Company Inc | Novel dentifrice composition |
WO2015157687A2 (en) * | 2014-04-11 | 2015-10-15 | Premier Dental Products Company | Enamel protectant and repair toothpaste treatments. |
WO2015171837A1 (en) * | 2014-05-09 | 2015-11-12 | The Procter & Gamble Company | Oral compositions containing zinc |
MX363313B (es) * | 2014-06-18 | 2019-03-20 | Colgate Palmolive Co | Dentifrico que comprende complejo de zinc-aminoacido y fosfatos. |
CA2952921C (en) * | 2014-06-20 | 2021-06-15 | Colgate-Palmolive Company | Oral compositions containing zinc, stannous and fluoride ion sources |
CN110123669B (zh) * | 2014-06-20 | 2022-06-03 | 高露洁-棕榄公司 | 含有金属离子的口腔组合物 |
MX2020001180A (es) * | 2014-12-18 | 2022-05-12 | Gaba Int Holding Gmbh | Formulaciones de enjuague bucal. |
CN106999392A (zh) * | 2014-12-19 | 2017-08-01 | 高露洁-棕榄公司 | 牙齿美白口腔护理产品 |
CA2971409C (en) | 2014-12-26 | 2022-01-11 | Colgate-Palmolive Company | Low water dentifrice compositions |
CA2981006C (en) | 2015-05-01 | 2023-01-03 | Colgate-Palmolive Company | Low water dentifrice compositions comprising a calcium pyrophosphate base |
AU2016286006B2 (en) | 2015-07-01 | 2018-06-21 | Colgate-Palmolive Company | Oral care compositions and methods of use |
EP3380064B1 (en) * | 2015-12-30 | 2020-05-06 | Colgate-Palmolive Company | Personal care compositions |
US10226407B2 (en) | 2015-12-30 | 2019-03-12 | Colgate-Palmolive Company | Oral care compositions |
US10500142B2 (en) | 2015-12-30 | 2019-12-10 | Colgate-Palmolive Company | Oral care compositions |
MX370240B (es) * | 2015-12-30 | 2019-12-06 | Colgate Palmolive Co | Composiciones para el cuidado personal. |
WO2017219339A1 (en) | 2016-06-24 | 2017-12-28 | Colgate-Palmolive Company | Oral care compositions and methods of use |
MX2018015740A (es) | 2016-06-24 | 2019-04-29 | Colgate Palmolive Co | Composiciones para el cuidado bucal y metodos de uso. |
CA2996319C (en) | 2016-06-24 | 2020-09-15 | Colgate-Palmolive Company | High water oral care composition comprising zinc and tin salts |
MX369281B (es) * | 2016-06-24 | 2019-11-04 | Colgate Palmolive Co | Composiciones para el cuidado bucal y metodos para utilizar las composiciones. |
RU2702092C2 (ru) * | 2016-06-24 | 2019-10-04 | Колгейт-Палмолив Компани, Сша | Композиции для ухода за полостью рта и способы их применения |
CN109328092A (zh) * | 2016-06-24 | 2019-02-12 | 高露洁-棕榄公司 | 口腔护理组合物 |
BR112018075162B1 (pt) * | 2016-06-24 | 2022-03-22 | Colgate-Palmolive Company | Composições para higiene bucal e usos relacionados |
CN108024916B (zh) * | 2016-06-24 | 2021-10-01 | 高露洁-棕榄公司 | 口腔护理组合物及使用方法 |
CA3047925C (en) | 2016-12-21 | 2021-03-30 | Colgate-Palmolive Company | High water oral care compositions comprising zinc phosphate, stannous fluoride, arginine or lysine, and an organic buffer system |
AU2017382466B2 (en) * | 2016-12-21 | 2020-03-05 | Colgate-Palmolive Company | Oral care compositions and methods of use |
US10646420B2 (en) * | 2016-12-21 | 2020-05-12 | Colgate-Palmolive Company | Oral care compositions and methods of use |
US10195128B2 (en) | 2016-12-21 | 2019-02-05 | Colgate-Palmolive Company | Oral care compositions |
CA3047940C (en) | 2016-12-21 | 2020-04-28 | Colgate-Palmolive Company | Oral care compositions |
RU2692249C2 (ru) * | 2017-01-31 | 2019-06-24 | Колгейт-Палмолив Компани | Средство для ухода за зубами на основе ионов металлов с низким содержанием воды |
US11517523B2 (en) * | 2017-09-12 | 2022-12-06 | IntraMont Technologies, Inc. | Oral-surface administered preparation for the prevention of illnesses acquired via the oral cavity and the pharynx |
EP3705112A4 (en) * | 2017-10-30 | 2021-08-25 | LG Household & Health Care Ltd. | PUMP-LIKE TOOTHPASTE COMPOSITION |
CN112135600B (zh) | 2018-05-14 | 2024-01-02 | 宝洁公司 | 发泡口腔护理组合物 |
US11911492B2 (en) | 2018-05-14 | 2024-02-27 | The Procter & Gamble Company | Oral care compositions comprising metal ions |
US11395791B2 (en) * | 2018-12-26 | 2022-07-26 | Colgate-Palmolive Company | Methods of inducing sIgA and mucin 5b in the oral cavity |
EP3903764A4 (en) * | 2018-12-28 | 2022-10-12 | Teixeira, Marcelo Rodrigues | MULTIFUNCTIONAL BIPHOSPHATE FLUORIDE TOOTHPASTE COMPOSITION |
EP3975979A1 (en) | 2019-07-01 | 2022-04-06 | Colgate-Palmolive Company | Oral care compositions and methods |
AU2020360256B2 (en) * | 2019-09-30 | 2024-03-28 | The Procter & Gamble Company | Oral care compositions comprising hops beta acid and metal ion |
WO2021062607A1 (en) | 2019-09-30 | 2021-04-08 | The Procter & Gamble Company | Oral care compositions comprising hops beta acid and amino acid |
WO2021216394A1 (en) * | 2020-04-20 | 2021-10-28 | The Procter & Gamble Company | Toothpaste compositions comprising silica and surface active polymer |
Family Cites Families (136)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2946725A (en) | 1957-03-25 | 1960-07-26 | Procter & Gamble | Dentifrice compositions |
US3070510A (en) | 1959-11-03 | 1962-12-25 | Procter & Gamble | Dentifrice containing resinous cleaning agents |
US3538230A (en) | 1966-12-05 | 1970-11-03 | Lever Brothers Ltd | Oral compositions containing silica xerogels as cleaning and polishing agents |
US3678154A (en) | 1968-07-01 | 1972-07-18 | Procter & Gamble | Oral compositions for calculus retardation |
US3980767A (en) | 1968-07-23 | 1976-09-14 | Beecham Group Limited | Gel toothpastes |
US3959458A (en) | 1973-02-09 | 1976-05-25 | The Procter & Gamble Company | Oral compositions for calculus retardation |
US3862307A (en) | 1973-04-09 | 1975-01-21 | Procter & Gamble | Dentifrices containing a cationic therapeutic agent and improved silica abrasive |
US4100269A (en) | 1973-06-28 | 1978-07-11 | Lever Brothers Company | Anticalculus dentifrice |
US4022880A (en) | 1973-09-26 | 1977-05-10 | Lever Brothers Company | Anticalculus composition |
US3966863A (en) | 1974-12-04 | 1976-06-29 | Beecham Group Limited | Oral hygiene compositions |
US3965863A (en) | 1975-04-07 | 1976-06-29 | Scott Harry M | Chemical litter unit |
US4051234A (en) | 1975-06-06 | 1977-09-27 | The Procter & Gamble Company | Oral compositions for plaque, caries, and calculus retardation with reduced staining tendencies |
US4206215A (en) | 1976-02-25 | 1980-06-03 | Sterling Drug Inc. | Antimicrobial bis-[4-(substituted-amino)-1-pyridinium]alkanes |
US4138477A (en) | 1976-05-28 | 1979-02-06 | Colgate Palmolive Company | Composition to control mouth odor |
US4421527A (en) | 1977-12-20 | 1983-12-20 | J. M. Huber Corporation | High fluoride compatibility dentifrice abrasives and compositions |
DE2960420D1 (en) | 1978-07-12 | 1981-09-24 | Beecham Group Plc | Method of inhibiting corrosion of aluminium tubes by toothpastes |
US4358437A (en) | 1978-11-29 | 1982-11-09 | Beecham Group Limited | Compositions |
US4420312A (en) | 1979-05-23 | 1983-12-13 | J. M. Huber Corporation | Method for production of high fluoride compatibility dentifrice abrasives and compositions |
US4340583A (en) | 1979-05-23 | 1982-07-20 | J. M. Huber Corporation | High fluoride compatibility dentifrice abrasives and compositions |
US4416867A (en) | 1979-06-20 | 1983-11-22 | Lever Brothers Company | Oral compositions |
US4425325A (en) | 1979-06-20 | 1984-01-10 | Lever Brothers Company | Oral compositions |
US4328705A (en) | 1980-08-11 | 1982-05-11 | Schlumberger Technology Corporation | Method of determining characteristics of a fluid producing underground formation |
US4325939A (en) | 1980-09-22 | 1982-04-20 | Richardson-Vicks Inc. | Zinc derivatives and their use in dental compositions |
US4289755A (en) | 1980-11-03 | 1981-09-15 | Richardson-Vicks Inc. | Stable mouthwash compositions containing zinc and fluoride compounds |
US4289754A (en) | 1980-11-03 | 1981-09-15 | Richardson-Vicks Inc. | Zinc derivatives and their use in mouthwash compositions |
EP0095871A3 (en) | 1982-05-27 | 1984-06-13 | Reckitt And Colman Products Limited | Improvements in or relating to tooth treatment compositions |
US4568540A (en) | 1984-04-18 | 1986-02-04 | Johnson & Johnson | Oral hygiene compositions |
GB8411731D0 (en) | 1984-05-09 | 1984-06-13 | Unilever Plc | Oral compositions |
US4647451A (en) | 1984-05-11 | 1987-03-03 | Colgate-Palmolive Company | Anhydrous dentifrice |
US4627977A (en) | 1985-09-13 | 1986-12-09 | Colgate-Palmolive Company | Anticalculus oral composition |
JPH0747531B2 (ja) | 1986-06-27 | 1995-05-24 | ライオン株式会社 | 口腔用組成物 |
US5000921A (en) | 1986-10-24 | 1991-03-19 | Hanaway Richard W | Multiple pipette samples |
US4894270A (en) | 1986-12-04 | 1990-01-16 | Nicholls Robert L | Fold and bond for constructing cement laminate structural shapes |
US5288480A (en) | 1987-01-30 | 1994-02-22 | Colgate-Palmolive Co. | Antiplaque antibacterial oral composition |
US4894220A (en) | 1987-01-30 | 1990-01-16 | Colgate-Palmolive Company | Antibacterial antiplaque oral composition |
AU1746088A (en) | 1987-06-12 | 1988-12-15 | Unilever Plc | Oral compositions |
US5004597A (en) | 1987-09-14 | 1991-04-02 | The Procter & Gamble Company | Oral compositions comprising stannous flouride and stannous gluconate |
US5000944A (en) | 1989-06-09 | 1991-03-19 | Colgate-Palmolive Company | Zinc-containing oral products with reduced astringency |
US4937066A (en) | 1989-06-22 | 1990-06-26 | David G. Vlock | Zinc containing oral compositions |
GB8922434D0 (en) * | 1989-10-05 | 1989-11-22 | Unilever Plc | Oral compositions |
US5354551A (en) | 1989-10-14 | 1994-10-11 | Desitin Arzneimittel Gmbh | Oral and dental hygiene preparation |
US5015466A (en) | 1990-06-26 | 1991-05-14 | The Procter & Gamble Company | Anticalculus compositions using tartrate-succinates |
WO1992010994A1 (en) | 1990-12-18 | 1992-07-09 | The Procter & Gamble Company | Oral compositions effective against plaque and gingivitis |
GB9107833D0 (en) | 1991-04-12 | 1991-05-29 | Unilever Plc | Treatment of periodontitis |
GB9117140D0 (en) | 1991-08-08 | 1991-09-25 | Unilever Plc | Treatment of periodontitis |
US5240697A (en) | 1991-10-17 | 1993-08-31 | Colgate-Palmolive Company | Desensitizing anti-tartar dentifrice |
US5374417A (en) | 1991-10-17 | 1994-12-20 | Colgate Palmolive Company | Desensitizing dentifrice |
US5270031A (en) | 1991-12-20 | 1993-12-14 | Block Drug Company Inc. | Dentinal desensitizing compositions |
FR2688136B1 (fr) | 1992-03-03 | 1995-06-09 | Oreal | Composition cosmetique contenant des pigments melaniques en association avec certains tocopherols, et procede de protection de la peau, des cheveux, des muqueuses et des compositions cosmetiques. |
EP0675705A1 (en) | 1992-12-18 | 1995-10-11 | The Procter & Gamble Company | Oral compositions containing antiplaque, anticalculus agents |
HUT72041A (en) | 1992-12-18 | 1996-03-28 | Procter & Gamble | Oral compositions containing antiplaque, anticalculus agents |
AU6721494A (en) | 1993-05-13 | 1994-12-12 | Unilever Plc | Oral compositions containing triclosan for the treatment of aphthous ulcers |
FR2708850B1 (fr) | 1993-08-11 | 1995-09-22 | Oreal | Composition de dentifrice anhydre. |
US5372803A (en) | 1993-09-02 | 1994-12-13 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Dental compositions with zinc and bicarbonate salts |
WO1995007682A1 (en) | 1993-09-16 | 1995-03-23 | Unilever N.V. | Oral compositions containing stannous compounds |
EP0657160A1 (en) | 1993-12-09 | 1995-06-14 | Unilever N.V. | Oral composition for desensitising sensitive teeth |
NZ288826A (en) | 1994-06-06 | 1998-09-24 | Block Drug Co | Phosphate-free composition containing cationically charged sub-micron colloidal particles, relief of dental hypersensitivity |
US5505933A (en) | 1994-06-27 | 1996-04-09 | Colgate Palmolive Company | Desensitizing anti-tartar dentifrice |
DE9411517U1 (de) | 1994-07-15 | 1995-08-17 | Boehringer Mannheim Gmbh, 68305 Mannheim | Verdrehsicherung für Reagenzgefäße |
US5603920A (en) | 1994-09-26 | 1997-02-18 | The Proctor & Gamble Company | Dentifrice compositions |
US5578293A (en) | 1994-12-06 | 1996-11-26 | Colgate Palmolive Company | Oral compositions containing stabilized stannous compounds having antiplaque and antitartar efficacy |
US5670137A (en) | 1994-12-12 | 1997-09-23 | L'oreal | Anhydrous dentifrice composition |
US5487906A (en) | 1994-12-15 | 1996-01-30 | Colgate-Palmolive Company | Method of forming stable aqueous solutions of stannous compounds |
US6024891A (en) | 1994-12-22 | 2000-02-15 | The Procter & Gamble Company | Silicone compositions |
US6123950A (en) | 1994-12-22 | 2000-09-26 | The Procter & Gamble Company | Silicone compositions |
US5759523A (en) | 1994-12-22 | 1998-06-02 | The Procter & Gamble Company | Detergent compositions comprising a dimethicone copolyol |
US5578295A (en) | 1995-04-28 | 1996-11-26 | The Procter & Gamble Company | Oral care compositions comprising certain substituted diphenyl ethers |
US5658553A (en) | 1995-05-02 | 1997-08-19 | The Procter & Gamble Company | Dentifrice compositions |
US5589160A (en) | 1995-05-02 | 1996-12-31 | The Procter & Gamble Company | Dentifrice compositions |
US5651958A (en) | 1995-05-02 | 1997-07-29 | The Procter & Gamble Company | Dentifrice compositions |
US5546658A (en) | 1995-08-14 | 1996-08-20 | David L. MacLeod | Nail clipping and collecting device |
US6139823A (en) | 1995-11-07 | 2000-10-31 | The Procter & Gamble Company | Transfer resistant cosmetic compositions |
US6019962A (en) | 1995-11-07 | 2000-02-01 | The Procter & Gamble Co. | Compositions and methods for improving cosmetic products |
US5716600A (en) | 1995-11-14 | 1998-02-10 | Professional Dental Technologies, Inc. | Stable stannous fluoride toothpaste compositions |
US5716601A (en) | 1996-03-22 | 1998-02-10 | The Procter & Gamble Company | Dentifrice compositions |
BR9712645A (pt) | 1996-10-22 | 1999-10-26 | Procter & Gamble | Composição orais contendo sais de citrato de zinco |
NZ335780A (en) | 1996-10-23 | 2001-01-26 | Univ New York State Res Found | Compositions to control oral microbial oxidation-reduction (Eh) levels and treat gingivitis-periodontitis |
US20030206874A1 (en) | 1996-11-21 | 2003-11-06 | The Proctor & Gamble Company | Promoting whole body health |
US6350436B1 (en) | 1996-11-21 | 2002-02-26 | The Procter & Gamble Company | Method of reducing staining of stannous in dentifrice compositions |
US5939052A (en) | 1996-11-21 | 1999-08-17 | The Procter & Gamble Company | Dentifrice compositions containing polyphosphate and fluoride |
US6190644B1 (en) | 1996-11-21 | 2001-02-20 | The Procter & Gamble Company | Dentifrice compositions containing polyphosphate and monofluorophosphate |
US5900230A (en) | 1997-08-18 | 1999-05-04 | Squigle, Inc. | Dental products to treat and prevent periodontal disease |
US5948390A (en) | 1997-08-25 | 1999-09-07 | Pfizer Inc. | Stable zinc/citrate/CPC oral rinse formulations |
RU2131720C1 (ru) | 1997-10-30 | 1999-06-20 | Московский областной научно-исследовательский клинический институт (МОНИКИ) | Паста для пломбирования корневых каналов зубов |
US5939051A (en) | 1998-02-27 | 1999-08-17 | Colgate-Palmolive Company | Dental abrasive |
EP1058534A1 (en) | 1998-03-06 | 2000-12-13 | Fmc Corporation | Non-stringy gel toothpaste comprising kappa carrageenan and cellulose as binders |
JP3763075B2 (ja) | 1998-04-24 | 2006-04-05 | サンスター株式会社 | 歯周病の予防又は治療用の食品組成物、口腔用組成物及び医薬組成物 |
US6187293B1 (en) | 1998-04-27 | 2001-02-13 | Fmc Corporation | Process for making toothpaste using low levels of carrageenan |
US6221340B1 (en) | 1999-04-08 | 2001-04-24 | Warner-Lambert Company | Zinc containing dentifrice compositions |
US6861048B2 (en) | 1999-04-08 | 2005-03-01 | Warner-Lambert Company | Dentifrice compositions having reduced abrasivity |
US6592882B2 (en) | 1999-05-26 | 2003-07-15 | Color Access, Inc. | Cosmetic compositions containing fluorescent minerals |
US6558710B1 (en) | 1999-06-14 | 2003-05-06 | Helen Rebecca Godfrey | Topical zinc compositions and methods of use |
CA2382599C (en) | 1999-08-30 | 2005-11-08 | Tepha, Inc. | Flushable disposable polymeric products |
US20030158111A1 (en) | 1999-10-01 | 2003-08-21 | David Bar-Or | Methods and products for oral care |
US6685920B2 (en) | 1999-11-12 | 2004-02-03 | The Procter & Gamble Company | Method of protecting teeth against erosion |
US20070025928A1 (en) * | 1999-11-12 | 2007-02-01 | The Procter & Gamble Company | Stannous oral care compositions |
JP2003526649A (ja) * | 2000-03-14 | 2003-09-09 | ザ、プロクター、エンド、ギャンブル、カンパニー | ポリホスフェート、フッ化物及びスズ(ii)塩を含む安定な歯磨き組成物 |
US6290933B1 (en) | 2000-05-09 | 2001-09-18 | Colgate-Palmolive Company | High cleaning dentifrice |
WO2002011682A2 (en) | 2000-08-07 | 2002-02-14 | Unilever N.V. | Oral composition comprising a silicone and a water-insoluble active agent |
US6403059B1 (en) | 2000-08-18 | 2002-06-11 | J. M. Huber Corporation | Methods of making dentifrice compositions and products thereof |
US6685921B2 (en) | 2000-10-25 | 2004-02-03 | The Procter & Gamble Company | Dental care compositions |
AU2002232507A1 (en) | 2000-12-05 | 2002-06-18 | Colgate-Palmolive Company | Zinc containing dentifrice of reduced astringency |
JPWO2002051404A1 (ja) | 2000-12-26 | 2004-04-22 | 株式会社産学連携機構九州 | 口腔用組成物 |
JP2004532831A (ja) | 2001-03-27 | 2004-10-28 | シー.エス. バイオサイエンス、 インコーポレイテッド | 歯科用調剤 |
MXPA04001555A (es) | 2001-08-21 | 2004-10-27 | Galileo Pharmaceuticals Inc | Composiciones enriquecidas con tocoferol y mejoramiento de sintomas inflamatorios. |
EP1418883A1 (en) | 2001-08-24 | 2004-05-19 | Unilever N.V. | Oral composition comprising an alkylhydroxybenzoate |
CA2468606C (en) | 2001-11-28 | 2011-01-25 | The Procter & Gamble Company | Dentifrice compositions comprising a stable low water phase comprising polyphosphate, ionic active ingredients and binder system |
KR100838478B1 (ko) | 2002-02-19 | 2008-06-16 | 주식회사 엘지생활건강 | 복합 비타민을 함유하는 치약 조성물 |
US6592852B1 (en) | 2002-04-25 | 2003-07-15 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Zinc citrate beads in oral compositions |
US6696645B2 (en) | 2002-05-08 | 2004-02-24 | The Regents Of The University Of Michigan | On-wafer packaging for RF-MEMS |
US7797403B2 (en) | 2002-07-12 | 2010-09-14 | Microsoft Corporation | Deployment of configuration information |
CA2505889A1 (en) | 2002-11-14 | 2004-06-03 | Smithkline Beecham Corporation | Controlled-dissolving polymeric device for the oral cavity |
US20040101494A1 (en) | 2002-11-26 | 2004-05-27 | Scott Douglas Craig | Chewable solid unit dosage forms and methods for delivery of active agents into occlusal surfaces of teeth |
US20040101493A1 (en) | 2002-11-26 | 2004-05-27 | Scott Douglas Craig | Chewable solid unit dosage forms and methods for delivery of active agents into occlusal surfaces of teeth |
ES2214135B1 (es) | 2003-02-21 | 2005-05-01 | Laboratorios Kin S.A. | Composicion para el tratamiento de la cavidad bucal y utilizaciones correspondientes. |
JP2005112852A (ja) | 2003-09-19 | 2005-04-28 | Sunstar Inc | 歯肉の炎症及び歯根膜喪失を抑制するための内服組成物 |
JP2005132768A (ja) | 2003-10-30 | 2005-05-26 | Sunstar Inc | 口腔用組成物 |
US20050096383A1 (en) | 2003-11-04 | 2005-05-05 | Ingvar Olafsson | Method and composition for oral cavity hygiene |
GB0401113D0 (en) * | 2004-01-19 | 2004-02-18 | Glaxo Group Ltd | Tooth whitening composition |
US7246684B2 (en) | 2004-02-26 | 2007-07-24 | Jlg Industries, Inc. | Boom lift vehicle and method of controlling boom angles |
WO2005092277A1 (en) | 2004-03-25 | 2005-10-06 | Unilever N.V. | Oral composition |
WO2006013081A1 (en) | 2004-08-02 | 2006-02-09 | Glaxo Group Limited | Novel composition for xerostomia |
US20060062744A1 (en) * | 2004-09-17 | 2006-03-23 | Jeffrey Lokken | Composition for whitening teeth and method of making the same |
EP1698324A1 (en) * | 2004-11-09 | 2006-09-06 | The Procter & Gamble Company | Zinc-containing dentifrice compositions having an improved taste |
US20060120975A1 (en) | 2004-12-02 | 2006-06-08 | Colgate-Palmolive Company | Oral care composition comprising a phenolic compound and antioxidant vitamins and vitamin derivatives |
US20060124035A1 (en) | 2004-12-09 | 2006-06-15 | Tuzeneau Walter K | Table with inclined work surface |
US20060134025A1 (en) * | 2004-12-17 | 2006-06-22 | Colgate-Palmolive Company | Oral compositions containing extracts of Rosmarinus and related methods |
US8974772B2 (en) | 2004-12-28 | 2015-03-10 | Colgate-Palmolive Company | Two phase toothpaste composition |
US20070014740A1 (en) * | 2005-07-15 | 2007-01-18 | Colgate-Palmolive Company | Oral compositions having cationic active ingredients |
JP2009520829A (ja) * | 2005-12-20 | 2009-05-28 | ザ プロクター アンド ギャンブル カンパニー | 亜鉛およびフィチン酸塩を含む口腔ケア組成物 |
AR058646A1 (es) | 2005-12-21 | 2008-02-13 | Colgate Palmolive Co | Composiciones orales mejoradas que comprenden citrato de zinc y/o agentes de tocoferol |
JP2009526040A (ja) * | 2006-02-10 | 2009-07-16 | エル・ジー ハウスホールド アンド ヘルスケア リミティッド | 同時溶解及びゲル化錠剤型の口腔衛生組成物 |
WO2007117498A2 (en) | 2006-04-07 | 2007-10-18 | The Procter & Gamble Company | Oral care regimens and kits |
MX2009003557A (es) | 2006-10-02 | 2009-04-15 | Procter & Gamble | Composicion estanosa para el cuidado bucal. |
CN102223867B (zh) * | 2008-11-25 | 2014-04-23 | 宝洁公司 | 改善的清洁口腔护理组合物 |
JP5681199B2 (ja) | 2009-10-29 | 2015-03-04 | コルゲート・パーモリブ・カンパニーColgate−Palmolive Company | フッ化第一スズとクエン酸亜鉛および低レベルの水を含む歯磨き剤 |
-
2009
- 2009-10-29 JP JP2012536771A patent/JP5681199B2/ja not_active Expired - Fee Related
- 2009-10-29 WO PCT/US2009/062452 patent/WO2011053291A1/en active Search and Examination
- 2009-10-29 CN CN200980162304.5A patent/CN102596154B/zh active Active
- 2009-10-29 IN IN2657DEN2012 patent/IN2012DN02657A/en unknown
- 2009-10-29 MY MYPI2012001485A patent/MY159488A/en unknown
- 2009-10-29 EP EP09744881.5A patent/EP2493445B1/en active Active
- 2009-10-29 RU RU2012122014/15A patent/RU2523900C2/ru active
- 2009-10-29 BR BR112012009305A patent/BR112012009305B8/pt not_active IP Right Cessation
- 2009-10-29 US US13/503,801 patent/US9968803B2/en active Active
- 2009-10-29 MX MX2012003731A patent/MX347064B/es active IP Right Grant
- 2009-10-29 CA CA2775444A patent/CA2775444C/en active Active
- 2009-10-29 AU AU2009354789A patent/AU2009354789B2/en active Active
-
2010
- 2010-10-28 TW TW099136828A patent/TWI440473B/zh not_active IP Right Cessation
- 2010-10-28 AR ARP100103975A patent/AR078814A1/es unknown
-
2012
- 2012-04-16 ZA ZA2012/02766A patent/ZA201202766B/en unknown
-
2018
- 2018-04-27 US US15/964,138 patent/US10682532B2/en active Active
- 2018-04-27 US US15/964,167 patent/US10668306B2/en active Active
-
2019
- 2019-10-23 US US16/660,851 patent/US11147992B2/en active Active
-
2020
- 2020-04-27 US US16/859,288 patent/US11285342B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5681199B2 (ja) | フッ化第一スズとクエン酸亜鉛および低レベルの水を含む歯磨き剤 | |
US10792231B2 (en) | Low water dentifrice compositions | |
JP4800576B2 (ja) | ポリリン酸塩及びイオン性活性成分を含む安定な低水相を含む歯磨剤組成物 | |
RU2699370C2 (ru) | Композиции в виде средства для чистки зубов с низким содержанием воды | |
AU2011369408B2 (en) | Low water metal ion dentifrice |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20131210 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140123 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20140423 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20140501 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140523 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20141210 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20150108 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5681199 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
LAPS | Cancellation because of no payment of annual fees |